Snowball logo
logo

Galectin Therapeutics Inc

GALT β€’ NASDAQ
$1.38-$0.02Β  (1.43%)
Start your journey to financial independence ✨
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently Asked Questions

What sector does Galectin Therapeutics Inc (GALT) operate in?

Galectin Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Galectin Therapeutics Inc (GALT) current stock price?

As of the latest data, Galectin Therapeutics Inc stock price is $1.38, with a previous close of $1.40. Galectin Therapeutics Inc lost -$0.02 in the last trading session, representing a -1.43% loss.

What is Galectin Therapeutics Inc (GALT) current market capitalization?

Galectin Therapeutics Inc market cap is approximately 86.61 million.

What is Galectin Therapeutics Inc (GALT) Earnings Per Share (EPS)?

The trailing EPS is -$0.73.

What is Galectin Therapeutics Inc (GALT) EBITDA?

Galectin Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -9.72 million.

Does Galectin Therapeutics Inc (GALT) dividends?

No. Galectin Therapeutics Inc does not pay a dividend.

When is Galectin Therapeutics Inc (GALT) next earnings report?

Galectin Therapeutics Inc is expected to release its next earnings report on March 31, 2025.